Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Amyloid Beta-protein”

87 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 87 results

Not applicableLooking for participantsNCT07623785
What this trial is testing

Assessing the Influence of Habitual Beef Intake on Key Molecular Markers of Brain Health

Who this might be right for
Healthy AgingBrain HealthCardiometabolic Health+2 more
South Dakota State University 20
Early research (Phase 1)Ended earlyNCT00657813
What this trial is testing

Evaluation of [123I] MNI-330 and SPECT as a Marker of Beta-amyloid Protein Deposition

Who this might be right for
Alzheimer Disease
Institute for Neurodegenerative Disorders 3
Testing effectiveness (Phase 2)Study completedNCT03417986
What this trial is testing

Clinical Trial to Explore the the Amyloid Beta Draining Effect of Thiethylperazine (TEP) in Subjects With Newly Diagnosed Early-to-mild Dementia Due to Alzheimer's Disease (AD) in Comparison to Healthy Volunteers

Who this might be right for
Alzheimer Disease
Immungenetics AG 20
Early research (Phase 1)Ended earlyNCT00870519
What this trial is testing

Brain Imaging Study in Subjects With Alzheimer Disease in Comparison to Healthy Subjects

Who this might be right for
Alzheimer's Disease
Institute for Neurodegenerative Disorders 2
Not applicableStudy completedNCT05521919
What this trial is testing

Acute Plasma Abeta Responses to Stress

Who this might be right for
Stress ReactionStress Physiology
University of Southern California 38
Not applicableUnknownNCT01128725
What this trial is testing

Truncated and Extended Forms of Amyloid Beta Peptides in Alzheimer's Disease: Genesis, Toxicity and Identification as Biological Markers

Who this might be right for
Alzheimer Disease
Centre Hospitalier Universitaire de Nice 100
Not applicableStudy completedNCT01425957
What this trial is testing

Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment

Who this might be right for
MILD COGNITIVE IMPAIRMENT
Qualissima 229
Testing effectiveness (Phase 2)Study completedNCT00928304
What this trial is testing

Phase II Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid.

Who this might be right for
Down SyndromeAmyloid Beta-protein
Lantheus Biosciences Ltd. 109
Large-scale testing (Phase 3)Study completedNCT01020838
What this trial is testing

Phase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid Compared to Histopathology

Who this might be right for
Alzheimer Disease
Lantheus Biosciences Ltd. 218
Not applicableStudy completedNCT02129452
What this trial is testing

Olfactory Neuroepithelial Tissue of Alzheimer Disease

Who this might be right for
Alzheimer Disease
Seoul National University Hospital 40
Not applicableStudy completedNCT02021682
What this trial is testing

CNS and Plasma Amyloid-Beta Kinetics in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Washington University School of Medicine 58
Not applicableStudy completedNCT06604390
What this trial is testing

THE EFFECTS OF GAMBIR CATECHIN (UNCARIA GAMBIR ROXB) SUPPLEMENTATION ON COGNITIVE FUNCTION, EXPRESSION OF APP, MAPT, BDNF, IL-10, TGF-Β GENES, AND PLASMA MDA LEVELS IN THE ELDERLY.

Who this might be right for
Elderly Individuals Aged 60 Years or OlderMild Cognitive Impairment (MCI)
Rahmi Novita Yusuf 64
Early research (Phase 1)Not Yet RecruitingNCT07568041
What this trial is testing

Phase 1 Study to Evaluate the Safety and Tolerability of 8M2D in Healthy People and Alzheimer's Patients

Who this might be right for
Alzheimer's Disease (AD)
Cenna Biosciences Inc. 54
Early research (Phase 1)Study completedNCT02033668
What this trial is testing

Pharmacokinetic (PK) Study of GSK933776 in Healthy Volunteers

Who this might be right for
Atrophy, Geographic
GlaxoSmithKline 36
Early research (Phase 1)Study completedNCT00556660
What this trial is testing

Evaluation of [123I] AV51 and SPECT as a Marker of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects

Who this might be right for
Alzheimer Disease
Institute for Neurodegenerative Disorders 20
Early research (Phase 1)Study completedNCT00439010
What this trial is testing

Use of [123I] AV39 and SPECT Imaging as a Marker of Protein Disposition in Subjects With Alzheimer Disease Compared to Healthy Subjects

Who this might be right for
Alzheimers Disease
Molecular NeuroImaging 30
Not applicableUnknownNCT05002699
What this trial is testing

Investigating the Impact of Alzheimer's Disease Diagnostics in British Columbia

Who this might be right for
Alzheimer DiseaseDementiaCognitive Impairment+1 more
University of British Columbia 120
Early research (Phase 1)Ended earlyNCT00605046
What this trial is testing

Evaluation of [123I] AV151 and SPECT in Subjects w/ AD in Comparison to Healthy Subjects

Who this might be right for
Alzheimer Disease
Institute for Neurodegenerative Disorders 1
Early research (Phase 1)Study completedNCT00287248
What this trial is testing

Assess 123-I IMPY and SPECT Imaging as a Tool to Detect β-Amyloid in the Brain

Who this might be right for
Alzheimer Disease
Institute for Neurodegenerative Disorders 38
Testing effectiveness (Phase 2)Ended earlyNCT00500500
What this trial is testing

Effect of EGb 761® on Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Ipsen 40
Next Page